Amerigen Pharmaceuticals Inc. recalls Temozolomide Capsules, 180 mg, packaged in a 14 count bottles, Rx only, Mfd, by: Stason Pharmaceuticals, Inc., Irvine, C
Recalled January 2, 2019 · FDA recall D-0345-2019 · Amerigen Pharmaceuticals
Hazard
Failed Dissolution Specifications · FDA Class III
Units
771 bottles
Sold at
Product was distributed to 4 wholesalers and 2 retail accounts who may have further distributed the products.
Description
Failed Dissolution Specifications
Product
Temozolomide Capsules, 180 mg, packaged in a 14 count bottles, Rx only, Mfd, by: Stason Pharmaceuticals, Inc., Irvine, CA, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ ---- NDC 43975-256-14
Manufacturer(s)
Amerigen Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →